Achieve Life Sciences ACHV Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Achieve Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost.
The official record: Achieve Life Sciences’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Achieve Life Sciences's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Achieve Life Sciences's stock-based comp?
- Achieve Life Sciences (ACHV) reported stock-based comp of $269.25K in Q4 2025.
- How has Achieve Life Sciences's stock-based comp changed year-over-year?
- Achieve Life Sciences's stock-based comp increased by 76.6% year-over-year, from $152.5K to $269.25K.
- What is the long-term trend for Achieve Life Sciences's stock-based comp?
- Over 2 years (2023 to 2025), Achieve Life Sciences's stock-based comp has grown at a 73.0% compound annual growth rate (CAGR), from $360K to $1.08M.
- What does stock-based comp mean?
- This represents the dollar amount of share-based compensation that is considered nondeductible for income tax purposes. It highlights the tax impact of equity-based incentive programs. This metric helps investors understand the effective tax cost of employee compensation structures.